Short answer. The notice says HHS does not intend to take enforcement action against a state-licensed pharmacy, a federal facility, or a licensed physician compounding with a peptide in Appendix A [1]. An outsourcing facility is not in that list. As of Oct 29, 2026.

503A and 503B are different doors

Section 503A is the pharmacy and physician path: a patient-specific prescription, and the other conditions the policy repeats [2]. Section 503B is the outsourcing-facility path. Those facilities register with FDA, follow manufacturing-practice rules, and can produce compounded drugs without a prescription for an identified patient in the way 503A requires. The Oct 28 notice is titled as a 503A policy [1]. Its "does not intend" sentence matches the 503A compounders, not an outsourcing facility [1].

The policy's background mentions outsourcing facilities once, in a general definition of compounding [2]. That definition is not the enforcement sentence. The enforcement sentence names the state-licensed pharmacy, the federal facility, and the licensed physician [1][2].

What not to assume

Do not read the notice as a ban written in those words. Read it as silence. This discretion is not addressed to 503B facilities. A facility that is 503B still has its own bulks rules. "The peptide announcement" is not a new 503B permission slip.

It also is not permission for a clinic to buy office stock from a compounder and skip the patient-specific prescription. Condition 10 keeps that prescription requirement for this policy [2].

The longer map of both sections is Are peptides legal?.

FAQ

Our supplier says they are a 503B and the new policy covers their peptide vials. What should I ask? Ask them to point to the sentence that names outsourcing facilities. The sentence in the notice does not [1].

Does this make 503A pharmacies into manufacturers? No. The policy keeps the other 503A requirements, including the prescription [2].

Sources

1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

2. HHS policy, background and conditions. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

Sommar Club does not prescribe or sell these six. Education only. Not medical or legal advice. As of Oct 29, 2026.